Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 16, 2015

Drug Name Review Type Class Manufacturer
Praluent New Drug Initial Review Cholesterol Lowering Sanofi
Daklinza New Drug Initial Review Hepatitis C Bristol-Myers Squibb
Cosentyx New Drug Initial Review Psoriasis Novartis
Feraheme New Drug Initial Review Intravenous Iron Amag
Technivie New Drug Initial Review Hepatitis C AbbVie
Corlanor New Drug Initial Review Heart Failure Amgen
Triumeq New Drug Initial Review HIV ViiV Healthcare
Entresto New Drug Initial Review Chronic Heart Failure Novartis
Invega Trinza New Drug Initial Review Atypical Antipsychotic Janssen Pharmaceuticals